Presenter: Dr. Allison Smith 

Join Dr. Allison Smith for a discussion on how to interpret the estrogen part of the ZRT urine metabolites panel – line by line.

Discussion will include:

• High E2 tissue exposure as an independent risk factor for breast cancer
• Using the estrogen quotient to assess risk
• Estrogens are moved through several different pathways or cytochrome systems to find their natural exit from the body
• Learn more about these cytochrome systems
• The 2/16 ratio
• Learn how we assess methylation by looking at patterns and levels of these products in the urine
• BPA's estrogenic potential

• Web: Metabolites Testing Profile
• Webinar: Estrogen Metabolism & Breast Cancer Risk
• Listen to the webinar: